Home > Cashflow Statement > BIOCON

BIOCON
Cash Flow from Financing Activities

    Back to Cashflow Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr₹388 Cr

What is the latest Cash Flow from Financing Activities ratio of BIOCON ?

The latest Cash Flow from Financing Activities ratio of BIOCON is ₹-2,333 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-2,333 Cr
Mar2023₹13,049 Cr
Mar2022₹242 Cr
Mar2021₹2,564 Cr
Mar2020₹388 Cr

How is Cash Flow from Financing Activities of BIOCON Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-2,333 Cr
Negative
Mar2023 ₹13,049 Cr
5,289.80
Mar2022 ₹242 Cr
-90.56
Mar2021 ₹2,564 Cr
561.51
Mar2020 ₹388 Cr -

Compare Cash Flow from Financing Activities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹41,594.8 Cr -1.1% -1.8% 40.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 4.6% 47.5% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr 1% -3.2% 59.3% Stock Analytics
CIPLA ₹120,270.0 Cr -1.1% -0.3% 20.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 2.2% 12.1% 21.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -2.7% 0.8% 43.8% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.1%

-1.8%

40.4%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses